AML - 498
Favorable Outcomes Including Post-Transplant Survival Are Seen Independent of Baseline Skin Burden in Treatment-Naοve Patients (Pts) With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Treated With Tagraxofusp (TAG): Subgroup Analysis of a Pivotal Trial
Eunice S Wang
Poster Presenter: Eunice S Wang
